Log In     Register
Forget your password ? Click Here
     
Find a Doctor

JUVÉDERM VOLUMA XC injectable gel is the first and only filler FDA-approved to instantly add volume to the cheek area. It gives you a subtle lift, helping restore contour and a more youthful profile for up to 2 years. JUVÉDERM VOLUMA XC is for patients over the age of 21.

Learn More
Find a Doctor

Doctors are now being trained by Allergan to use JUVÉDERM VOLUMA XC injectable gel - the first and only filler FDA-approved to instantly add volume to the cheek area. It gives you a subtle lift, helping restore contour and a more youthful profile for up to 2 years. JUVÉDERM VOLUMA XC is for patients over the age of 21.

Find a Doctor

The first and most important step!
Find a JUVÉDERM® XC doctor near you.

Before and After Before and After

BeforeAfter

Individual results may vary.

Brilliant Distinctions</i>® Program

Check out the benefits program that rewards your loyalty to JUVÉDERM® XC and other Allergan products.

JuvÉderm XC Stories

""

-

Individual results may vary.

Like BOTOX® Cosmetic?

You'll love JUVÉDERM® XC.

Same real, noticeable results - different treatment. JUVÉDERM® XC is a dermal filler that smoothes away facial wrinkles and folds, giving you a smooth, natural look and feel. See which treatment is best for you!

Before Treatment

Before you decide on treatment with JUVÉDERM® XC injectable gel, you'll want to find an experienced healthcare professional-someone who is familiar with the injection process.

Find a Doctor

Sign Up

Earn double the points on your first JUVÉDERM® XC treatment when you sign up for the Brilliant Distinctions® Program.

Join Today

A Fan in the Public Eye

As a TV entertainment reporter, Dayna Devon knows how important it is to keep her look fresh.

With all eyes on her, see why Dayna's a JUVÉDERM® XC Facebook fan >>

Most Viewed Videos

Where should you start? Try our most popular user videos. Hear the insights, experiences, and success stories that helped others on their JUVÉDERM® journey.

See Videos >>

Connect

Connect with other JUVÉDERM®XC fans and users by joining our growing community on facebook. Be the first to hear about fan rewards, talk to other users, and spread the word about JUVÉDERM®XC!

Become a Fan >>

Safety Considerations

With any cosmetic treatment, safety is the first concern. As always, it’s important to consult with your doctor before deciding on a wrinkle treatment. Because JUVÉDERM® injectable gel is a non-surgical, in-office treatment, most patients experience minimal recovery and downtime.

JUVÉDERM® and JUVÉDERM® XC Side Effects

JUVÉDERM® XC injectable gel is generally well tolerated. Most side effects are mild to moderate in nature and their duration is short lasting (7 days or less). The most common side effects include, but are not limited to, temporary injection site reactions such as redness, pain/tenderness, firmness, swelling, lumps/bumps, bruising, itching, and discoloration. As with all skin injection procedures, there is a risk of infection.

Hyaluronic acid fillers are generally biocompatible, which means allergy skin testing is not required prior to treatment.

Allergies

If you're considering treatment with JUVÉDERM® injectable gel, your healthcare professional should ask about your medical history to determine if you are an appropriate candidate for treatment. JUVÉDERM® injectable gel for facial wrinkles and folds should not be used in patients who have:

  • Severe allergies marked by a history of anaphylaxis or history or presence of multiple severe allergies
  • A history of allergies to gram-positive bacterial proteins
  • JUVÉDERM® should not be used in patients with a history of allergies to lidocaine.

Post-treatment Considerations

Your healthcare professional will tell you what to expect following treatment with JUVÉDERM® injectable gel. You should ask your healthcare professional when makeup may be applied after your treatment.

You should avoid the following for at least 24 hours after treatment:

  • Strenuous exercise
  • Consumption of alcoholic beverages
  • Extended exposure to sun or heat

Exposure to any of the above may cause temporary redness, swelling, and/or itching at the injection sites. If there is swelling, you may need to place an ice pack over the swollen area. Be sure to report any redness and/or visible swelling that lasts for more than a few days or any other symptoms that cause you concern to your healthcare professional and/or contact Allergan Product Support at 1-877-345-5372.

Other Considerations

In addition, you and your healthcare professional should discuss the following important treatment considerations in order to help avoid unsatisfactory results and complications when using JUVÉDERM® injectable gel:

  • Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at the injection site. You should inform your healthcare professional before treatment if you are using these types of substances.
  • If laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after treatment with JUVÉDERM® injectable gel, there is a possible risk of an inflammatory reaction at the treatment site.
  • JUVÉDERM® injectable gel should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body's immune response, as there may be an increased risk of infection.
  • The safety of JUVÉDERM® injectable gel for use during pregnancy, in breastfeeding females, or in patients under 18 years has not been established.
  • The safety of JUVÉDERM® injectable gel hyaluronic acid dermal filler in patients with a history of excessive scarring (eg, hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied.

Your healthcare professional should also warn you that the safety and effectiveness of JUVÉDERM® injectable gel for the treatment of areas other than facial lines and facial folds (such as lips) have not been established in controlled clinical studies.

Persons of Color

JUVÉDERM® is the first FDA approved hyaluronic acid dermal filler with demonstrated safety and effectiveness in persons of color.1

Other Treatments

Other treatments for dermal soft tissue augmentation include bovine-based collagen and other hyaluronic acid-based dermal fillers. Aside from these treatments, additional options for the correction of facial folds and wrinkles do exist, including facial creams, chemical peels, and laser skin surface treatments, and may be discussed with your healthcare professional.

JUVÉDERM® and JUVÉDERM® XC Clinical Study Data

JUVÉDERM® Clinical Trial Results

A clinical study was performed in the US to compare JUVÉDERM® Ultra injectable gel and JUVÉDERM® Ultra Plus injectable gel with ZYPLAST® dermal filler (bovine-based collagen). In each study, subjects were followed for 24 weeks after administration with JUVÉDERM® injectable gel in one nasolabial fold (NLF) and ZYPLAST® dermal filler in the other. For both studies, injection site responses were similar in duration and frequency for the non-lidocaine formulation of JUVÉDERM® injectable gel and ZYPLAST® dermal filler treated sides. Responses were usually mild or moderate in severity, did not require intervention, and lasted 7 days or less.

Clinical trial of JUVÉDERM® Ultra injectable gel and ZYPLAST® dermal filler (146 total subjects): Percentage of subjects who reported common injection site responses.

Injection Site Responses N=146

Clinical trial of JUVÉDERM® Ultra Plus injectable gel and ZYPLAST® dermal filler (144 total subjects): Percentage of subjects who reported common injection site responses.

Injection Site Responses N=144

JUVÉDERM® XC Clinical Trial Results

A 2-week, randomized, controlled US clinical study for JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC compared with JUVÉDERM® Ultra and JUVÉDERM® Ultra Plus without lidocaine showed a similar safety profile in all subjects (N = 72), with the exception of fewer reports of pain/tenderness with the product containing lidocaine. Common treatment-site responses (CTR) are presented in Tables 1 and 2. Aside from injection-site responses, there were no adverse events related to the device, procedure, or anesthesia.

  • The most common injection-site responses for JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC were redness, swelling, tenderness, firmness, lumps/bumps, discoloration, and bruising
Injection Site Responses
Injection Site Responses